C. Hermann

发表

Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding

Søren Buus, Nicola Ternette, Pietro Roversi, 2015, eLife.

TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst

S. Stevanović, T. Elliott, J. Trowsdale, 2015, eLife.

Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway

J. Trowsdale, P. Lehner, K. Skjødt, 2013, Proceedings of the National Academy of Sciences.

Emerging functional roles of cathepsin E.

H. Kalbacher, Nousheen Zaidi, C. Hermann, 2008, Biochemical and biophysical research communications.

TB or not to be: what specificities and impact do antibodies have during tuberculosis?

C. Hermann, C. King, Clemens Hermann, 2021, Oxford open immunology.

MHC Class I Is Mutually Exclusive The Binding of TAPBPR and Tapasin to

C. Hermann, Lisa M. Strittmatter, L. Boyle, 2013 .

The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase.

H. Kalbacher, C. Gargett, C. Hermann, 2010, Stem cells and development.

A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells

J. Blackburn, C. Hermann, Shaun Garnett, 2022, Scientific Reports.

Associating H2O2-and NO-related changes in the proteome of Mycobacterium smegmatis with enhanced survival in macrophage

N. Soares, J. Blackburn, Bridget Calder, 2018, Emerging Microbes & Infections.

Cell Envelope Proteomics of Mycobacteria.

N. Soares, J. Blackburn, C. Hermann, 2020, Journal of proteome research.

TAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway

S. Stevanović, T. Elliott, N. Trautwein, 2017, eLife.

TAPBPR: a new player in the MHC class I presentation pathway.

J. Trowsdale, C. Hermann, L. Boyle, 2015, Tissue antigens.

Cell wall enrichment unveils proteomic changes in the cell wall during treatment of Mycobacterium smegmatis with sub-lethal concentrations of rifampicin.

A. Nel, N. Soares, J. Blackburn, 2018, Journal of proteomics.

A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live BCG.

K. Dheda, R. Meldau, A. Pooran, 2019, American journal of respiratory and critical care medicine.

TAPBPR mediates peptide dissociation from MHC class I using a leucine lever

S. Stevanović, C. Hermann, A. Marcu, 2018, bioRxiv.

The Binding of TAPBPR and Tapasin to MHC Class I Is Mutually Exclusive

C. Hermann, Lisa M. Strittmatter, L. Boyle, 2013, The Journal of Immunology.

TAPBPR isoforms exhibit altered association with MHC class I

J. Traherne, C. Hermann, L. Boyle, 2014, Immunology.

Gel-free sample preparation techniques and bioinformatic enrichment analysis to in depth characterise the cell wall proteome of mycobacteria

A. Nel, N. Soares, J. Blackburn, 2018, MethodsX.